Bank of America’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Bank of America’s Portfolio RCPI Stock Details RCPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-580	Closed	–	–	7745
2015 Q3	$0	Sell	580 -940	-62%	-$1.05K	﹤0.01%	7778
2015 Q2	$2K	Buy	1,520 +20	+1%	+$48	﹤0.01%	7090
2015 Q1	$4K	Hold	1,500	–	–	﹤0.01%	6604
2014 Q4	$7K	Sell	1,500 -682	-31%	-$3.59K	﹤0.01%	7200
2014 Q3	$15K	Sell	2,182 -21,564	-91%	-$213K	﹤0.01%	7192
2014 Q2	$350K	Buy	+23,746	New	+$412K	﹤0.01%	4977

Other funds holding RCPI

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

KCM

Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return

WealthPLAN Partners Omaha, Nebraska $523M AUM 23.92% 1-Year Est. Return

IWMPD

Integrated Wealth Management (Palm Desert) Palm Desert, California $299M AUM 13.41% 1-Year Est. Return

Bank of America's RCPI Position: Q4 2015 in Review

Bank of America sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2015, closing a stake of 580 shares.

Bank of America first reported a position in RCPI in Q2 2014 and held it in 6 quarters. The position peaked at $350K in Q2 2014. 9 funds tracked by Wall St. Rank hold RCPI as of Q4 2015.

Bank of America reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
Bank of America sold 580 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015.
Bank of America first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 6 quarters.
Bank of America's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $350K in Q2 2014.
9 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on Bank of America's 13F filing for Q4 2015, filed 16 Feb 2016.